|
|
Volumn 125, Issue 3, 2013, Pages 79-90
|
|
Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
LINAGLIPTIN;
PURINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
CARDIOVASCULAR DISEASE;
HUMAN;
HYPERGLYCEMIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
HUMANS;
HYPERGLYCEMIA;
HYPOGLYCEMIC AGENTS;
PURINES;
QUINAZOLINES;
|
|
EID: 84882285385
PISSN: None
EISSN: 19419260
Source Type: None
DOI: 10.3810/pgm.2013.05.2663 Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
